Target intelligence / Profile preview

Tumor Cell (via Beta Radiation)

Molecular classification: Cell

Overview

Tumor cells are targeted for destruction using beta radiation, typically delivered via radioimmunotherapy (RIT) or similar methods. The beta particles emitted by radioisotopes cause DNA damage, leading to cell death through various pathways like apoptosis and necrosis. The cross-fire effect allows for the killing of neighboring cells not directly targeted. While effective, this approach carries risks of off-target effects and myelosuppression.

Other names: Cancer Cell (via Beta Radiation)Malignant Cell (via Beta Radiation)

Mechanism of action

Induction of lethal DNA damage via beta radiation leading to cell death (apoptosis, necrosis, etc.)

Biological functions

Cell deathCell proliferation (uncontrolled)Tumorigenesis

Disease associations

Cancer

Safety considerations

Myelosuppression (bone marrow toxicity)Off-target irradiation of normal tissuesRadiation-induced bystander effect (RIBE)Immunomodulation (potentially both positive and negative effects)

Interacting drugs

Radioimmunotherapy (RIT)

3 more in the full profile.

Biomarkers

Tumor-associated antigens (for targeting)Expression levels of target antigen

Beyond the preview

Go deeper on Tumor Cell (via Beta Radiation).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor Cell (via Beta Radiation).

Explore the full profile